Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
18F-fluorodeoxyglucose (18F-FDG)
33%
4-phase
33%
Cervical Cancer
16%
Cervical Tumor
16%
Contraceptives
16%
Endometrial Cancer
16%
Endometrial Diseases
16%
Endometrial Tumor
16%
Endometrium
33%
FDG Uptake
66%
Female Patients
16%
Gynecologic Malignancies
16%
Hormonal Therapy
33%
Malignancy
16%
Menstrual Cycle
16%
Mid-cycle
16%
Oligomenorrhea
33%
Ovarian Cancer
33%
Ovarian Malignancy
16%
Ovulatory
16%
Patient Assessment
100%
Phase Cycle
16%
Physiologic
33%
Positron Emission Tomography-computed Tomography (PET-CT)
100%
Postmenopausal Patients
100%
Premenopausal Patients
100%
Proliferative Phase
16%
Secretory Activity
16%
Standardized Uptake Value
50%
Tumor Invasion
16%
Tumor Uptake
16%
Two-peak
16%
Medicine and Dentistry
Cancer
60%
Cervical Cancer
20%
Contraceptive Agent
20%
Endometrium
40%
Endometrium Tumor
20%
Fluorodeoxyglucose F 18
100%
Hormone Therapy
40%
Menstrual Cycle
20%
Neoplasm
40%
Oligomenorrhea
40%
Ovarian Cancer
40%
Patient Assessment
100%
Positron Emission Tomography-Computed Tomography
100%
Standardized Uptake Value
60%
Tumor Invasion
20%
Uterine Cancer
20%